Stefan Gattenlöhner

6.6k total citations · 1 hit paper
147 papers, 4.4k citations indexed

About

Stefan Gattenlöhner is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Stefan Gattenlöhner has authored 147 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 40 papers in Molecular Biology and 32 papers in Surgery. Recurrent topics in Stefan Gattenlöhner's work include Head and Neck Cancer Studies (16 papers), Sarcoma Diagnosis and Treatment (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Stefan Gattenlöhner is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Sarcoma Diagnosis and Treatment (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Stefan Gattenlöhner collaborates with scholars based in Germany, United States and Austria. Stefan Gattenlöhner's co-authors include Georg Ertl, Meinrad Beer, Stefan Frantz, Stefan Störk, Jörg Strotmann, Wolfram Voelker, Frank Weidemann, Sebastian Herrmann, Volkmar Lange and Markus Niemann and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Stefan Gattenlöhner

137 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis

2009 545 citations Stefan Frantz, Stefan Gattenlöhner et al. Circulation profile →

Peers

Countries citing papers authored by Stefan Gattenlöhner

Since Specialization

Citations

This map shows the geographic impact of Stefan Gattenlöhner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Gattenlöhner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Gattenlöhner more than expected).

Fields of papers citing papers by Stefan Gattenlöhner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Gattenlöhner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Gattenlöhner. The network helps show where Stefan Gattenlöhner may publish in the future.

Co-authorship network of co-authors of Stefan Gattenlöhner

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Gattenlöhner. A scholar is included among the top collaborators of Stefan Gattenlöhner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Gattenlöhner. Stefan Gattenlöhner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining failure patterns and dynamics in locally advanced pharyngeal and laryngeal SCC following radiotherapy: Real-World Insights in the modern Era! 2025 ·Clinical and Translational Radiation Oncology ·Linda Agolli, (unknown), (unknown), (unknown), Gabriele A. Krombach, Sebastian Harth, (unknown), (unknown), Stefan Gattenlöhner, Daniel Habermehl	1
2	Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia 2024 ·Nature Communications ·(unknown), Balachandar Selvakumar, Maximiliano Ruben Ferrero, Monika Heiner, (unknown), (unknown), Jochen Wilhelm, Marek Bartkuhn, Astrid Weiß, Ioannis Alexopoulos, Biruta Witte, Stefan Gattenlöhner, István Vadász, Rory E. Morty, Werner Seeger, Ralph T. Schermuly, Ana Ivonne Vazquez‐Armendariz, Susanne Herold	22
3	1383P Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations: Results from the RECAP study 2023 ·Annals of Oncology ·Anna Kron, Matthias Scheffler, Marcel Wiesweg, (unknown), (unknown), Stefan Gattenlöhner, Jens Kollmeier, Christoph D. Schubart, Tobias Gross, Melanie Demes, Stefanie Keymel, (unknown), Sabine Merkelbach‐Bruse, (unknown), (unknown), (unknown), (unknown), J. Wolf	0
4	Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region 2023 ·Cancers ·Steffen Wagner, (unknown), Nora Wuerdemann, (unknown), (unknown), Jörn Pons‐Kühnemann, Elena‐Sophie Prigge, Magnus von Knebel Doeberitz, Stefan Gattenlöhner, Tim Waterboer, Lea Schroeder, Christoph Arens, Jens Peter Klußmann, Claus Wittekindt	3
5	Correction: Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation 2021 ·British Journal of Cancer ·Steffen Wagner, Elena‐Sophie Prigge, Nora Wuerdemann, (unknown), (unknown), Shachi Jenny Sharma, (unknown), Magnus von Knebel Doeberitz, Thomas Dreyer, Stefan Gattenlöhner, Gregor Wolf, Jörn Pons‐Kühnemann, Claus Wittekindt, Jens Peter Klußmann	1
6	Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma 2020 ·Cancer Research ·Xiang Zheng, Andreas Weigert, Simone Reu, Stefan Günther, Siavash Mansouri, (unknown), Stefan Gattenlöhner, Friedrich Grimminger, Soni Savai Pullamsetti, Werner Seeger, H. Winter, Rajkumar Savai	154
7	LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma—Potential Biomarkers for Targeted Therapy Concepts 2020 ·International Journal of Molecular Sciences ·Nora Wuerdemann, (unknown), (unknown), (unknown), Claus Wittekindt, Christian U. Huebbers, Shachi Jenny Sharma, (unknown), Stefan Gattenlöhner, Reinhard Büttner, Ernst‐Jan M. Speel, (unknown), Steffen Wagner, Alexander Quaas, Jens Peter Klußmann	36
8	Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer 2020 ·Science Advances ·Poonam Sarode, Xiang Zheng, Georgia A. Giotopoulou, Andreas Weigert, Carsten Kuenne, Stefan Günther, (unknown), Stefan Gattenlöhner, Thorsten Stiewe, Bernhard Brüne, Friedrich Grimminger, Georgios T. Stathopoulos, Soni Savai Pullamsetti, Werner Seeger, Rajkumar Savai	133
9	Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains 2020 ·Clinical Cancer Research ·Sebastian Klein, Alexander Quaas, Jennifer Quantius, Heike Löser, Jörn Meinel, Martin Peifer, Steffen Wagner, Stefan Gattenlöhner, Claus Wittekindt, Magnus von Knebel Doeberitz, Elena‐Sophie Prigge, (unknown), Ka‐Won Noh, (unknown), Hans Christian Reinhardt, Reinhard Büttner, Jens Peter Klußmann, Nora Wuerdemann	38
10	Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation 2020 ·British Journal of Cancer ·Steffen Wagner, Elena‐Sophie Prigge, Nora Wuerdemann, (unknown), (unknown), Shachi Jenny Sharma, (unknown), Magnus von Knebel Doeberitz, Thomas Dreyer, Stefan Gattenlöhner, Gregor Wolf, Jörn Pons‐Kühnemann, Claus Wittekindt, Jens Peter Klußmann	31
11	Plasma Cell-Free Human Papillomavirus Oncogene E6 and E7 DNA Predicts Outcome in Oropharyngeal Squamous Cell Carcinoma 2020 ·Journal of Molecular Diagnostics ·(unknown), (unknown), Claus Wittekindt, Andreas Bräuninger, Ernst‐Jan M. Speel, Stefan Gattenlöhner, Gregor Wolf, Jens Peter Klußmann, Nora Wuerdemann, Steffen Wagner	35
12	Aneuploidy in children with relapsed B‐cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse 2019 ·British Journal of Haematology ·Stefanie Groeneveld‐Krentz, M. Schroeder, Michael J. Reiter, (unknown), (unknown), (unknown), Jana Hof, Christiane Chen‐Santel, Karin Nebral, Jutta Bradtke, Seval Türkmen, Claudia D. Baldus, Stefan Gattenlöhner, Oskar A. Haas, Arend von Stackelberg, Leonid Karawajew, Cornelia Eckert, Renate Kirschner‐Schwabe	16
13	Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer 2017 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Mehmet Kemal Tur, Stefan Gattenlöhner, Rainer Fischer, (unknown), Stefan Barth	12
14	The role of high-risk human papillomavirus infections in laryngeal squamous cell carcinoma 2017 ·European Archives of Oto-Rhino-Laryngology ·Claus Wittekindt, Nora Wuerdemann, Stefan Gattenlöhner, Alexander Brobeil, Małgorzata Wierzbicka, Steffen Wagner, Jens Peter Klußmann	20
15	Lung cancer–associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell–immune cell cross-talk 2017 ·Science Translational Medicine ·Soni Savai Pullamsetti, Baktybek Kojonazarov, (unknown), Henning Gall, (unknown), (unknown), Andreas Weigert, Nefertiti El-Nikhely, Hossein Ardeschir Ghofrani, Gabriele A. Krombach, Ludger Fink, Stefan Gattenlöhner, Ulf R. Rapp, Ralph T. Schermuly, Friedrich Grimminger, Werner Seeger, Rajkumar Savai	56
16	Unusual gastric mucosal infiltration by a medullary thyroid carcinoma: a case report 2016 ·Journal of Medical Case Reports ·Thomas Karrasch, (unknown), Fritz Roller, Andréas Schäffler, (unknown), Stefan Gattenlöhner	3
17	A Recurrent Activating PLCG1 Mutation in Cardiac Angiosarcomas Increases Apoptosis Resistance and Invasiveness of Endothelial Cells 2014 ·Cancer Research ·(unknown), Tilmann Spieker, Ulrike Gamerdinger, (unknown), Johannes Berger, Thomas Dreyer, Jürgen R. Sindermann, A. Hoffmeier, Stefan Gattenlöhner, Andreas Bräuninger	53
18	Induction of Endoplasmic Reticulum Stress by Sorafenib and Activation of NF-κB by Lestaurtinib as a Novel Resistance Mechanism in Hodgkin Lymphoma Cell Lines 2012 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Christoph Renné, Stefan Gattenlöhner, Tilmann Spieker, Andreas Bräuninger	18
19	A Collagen α2(I) Mutation Impairs Healing after Experimental Myocardial Infarction 2011 ·American Journal Of Pathology ·Ulrich Hofmann, Andreas Bonz, Stefan Frantz, Kai Hu, Christiane Waller, (unknown), (unknown), Stefan Gattenlöhner, Johann Bauersachs, Georg Ertl	15
20	Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction 2006 ·Circulation ·Matthias Nahrendorf, Kai Hu, Stefan Frantz, Farouc A. Jaffer, Ching‐Hsuan Tung, Karl‐Heinz Hiller, Sabine Voll, Peter Nordbeck, David E. Sosnovik, Stefan Gattenlöhner, Михаил С. Новиков, Gerhard Dickneite, Guy L. Reed, Peter M. Jakob, Anthony Rosenzweig, Wolfgang R. Bauer, Ralph Weissleder, Georg Ertl	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact